Smartleaf Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Smartleaf Asset Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.8K	Hold	1,061	–	–	﹤0.01%	2142
2026 Q1	$14.3K	Sell	1,061 -126	-11%	-$1.75K	﹤0.01%	2145
2025 Q4	$16.7K	Buy	1,187 +538	+83%	+$7.55K	﹤0.01%	2134
2025 Q3	$9.07K	Buy	649 +537	+479%	+$7.73K	﹤0.01%	2155
2025 Q2	$1.69K	Sell	112 -216	-66%	-$3.08K	﹤0.01%	2382
2025 Q1	$4.33K	Sell	328 -482	-60%	-$6.65K	﹤0.01%	2243
2024 Q4	$12.7K	Sell	810 -1,560	-66%	-$23.4K	﹤0.01%	1896
2024 Q3	$37.8K	Buy	2,370 +1,700	+254%	+$27.4K	﹤0.01%	1017
2024 Q2	$10.1K	Buy	+670	New	+$9.6K	﹤0.01%	1403

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Smartleaf Asset Management's RDY Position: Q2 2026 in Review

Smartleaf Asset Management held its Dr. Reddy's Laboratories (RDY) position steady in Q2 2026 at 1,061 shares worth $15.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2142.

Smartleaf Asset Management first reported a position in RDY in Q2 2024 and has held it in 9 quarters since. The position peaked at $37.8K in Q3 2024. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Smartleaf Asset Management held 1,061 shares of Dr. Reddy's Laboratories worth $15.8K as of Q2 2026.
Smartleaf Asset Management left its Dr. Reddy's Laboratories share count unchanged in Q2 2026.
Dr. Reddy's Laboratories made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2142 holding.
Smartleaf Asset Management first reported a position in Dr. Reddy's Laboratories in Q2 2024 and has held it in 9 quarters since.
Smartleaf Asset Management's Dr. Reddy's Laboratories position peaked at $37.8K in Q3 2024.
238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.